US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 3.540
  • +0.270+8.26%
Trading Feb 18 11:28 ET
1.05BMarket Cap-5.80P/E (TTM)

AbCellera Biologics Key Stats

AbCellera Biologics Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
7.58M
-17.62%
EPS
-0.15
+8.57%
Buy

Feb 14, 2025

AbCellera Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.969M--
Feb 27, 20252024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.969M--
Feb 27, 20252024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--

Unlock Free Earnings Estimates

AbCellera Biologics Earnings Reports

Read more

Trending Stocks

Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More